The reasons that NHE inhibitors delivered on reperfusion did not protect against I/R injury have been extensively reviewed, and the results are consistent with the preclinical data, which show that Na+ and Ca2+ levels increase during ischemia (167). This evidence concerns the gene SLC9C1 and ischemia.